vimarsana.com

Page 148 - அறிவியல் மற்றும் பலர் தொழில்நுட்பம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More

On Monday, Tilray, Inc. (NASDAQ:TLRY) and Aphria, Inc. (NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion. Benzinga spoke with Irwin Simon, CEO of the new combined company. Check out the video below: Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23. Jazz Pharmaceuticals (NASDAQ:JAZZ) finalized its acquisition of GW Pharmaceuticals plc. (NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion net of GW Pharma s cash. Meanwhile, Ascend Wellness Holdings (CSE:AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share.

Condori pide revisión antidroga en la Gobernación, la FELCN no encuentra sustancias controladas - La Razón

Condori pide revisión antidroga en la Gobernación, la FELCN no encuentra sustancias controladas - La Razón
la-razon.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from la-razon.com Daily Mail and Mail on Sunday newspapers.

El gobernador visitó el Oeste provincial

El gobernador visitó el Oeste provincial
elesquiu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elesquiu.com Daily Mail and Mail on Sunday newspapers.

El Colegio Divina Pastora crea un cinturón anticovid

El Colegio Divina Pastora crea un cinturón anticovid
leonoticias.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leonoticias.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.